LEVIN ALAN G 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Jun 2, 2022
Insider Transaction Report
Form 4
LEVIN ALAN G
Director
Transactions
- Award
Common Stock
2022-05-31$9.31/sh+1,138$10,595→ 3,197 total
Footnotes (1)
- [F1]Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $11,250, prorated to $10,597.83 based on the increase in the annual retainer fee effective April 18, 2022.